Novel chemoimmunotherapeutic strategy for hepatocellular carcinoma based on a genome-wide association study

Pharmacotherapeutic options are limited for hepatocellular carcinoma (HCC). Recently, we identified the anti-tumor ligand MHC class I polypeptide-related sequence A (MICA) gene as a susceptibility gene for hepatitis C virus-induced HCC in a genome-wide association study (GWAS). To prove the concept...

Descripción completa

Detalles Bibliográficos
Autores principales: Goto, Kaku, Annan, Dorcas A., Morita, Tomoko, Li, Wenwen, Muroyama, Ryosuke, Matsubara, Yasuo, Ito, Sayaka, Nakagawa, Ryo, Tanoue, Yasushi, Jinushi, Masahisa, Kato, Naoya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133582/
https://www.ncbi.nlm.nih.gov/pubmed/27910927
http://dx.doi.org/10.1038/srep38407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133582/
https://www.ncbi.nlm.nih.gov/pubmed/27910927
http://dx.doi.org/10.1038/srep38407

Ejemplares similares